◐ Shell
reader mode source ↗
Jump to content
From Wikipedia, the free encyclopedia
Psychedelic drug
Pharmaceutical compound
Ganesha
Clinical data
Other namesGANESHA; G; G-0; 3C-G; 3,4-Dimethyl-2,5-dimethoxyamphetamine; 2,5-Dimethoxy-3,4-dimethylamphetamine; 3-Methyl-DOM; 3-Me-DOM; DOG; DOG-0
Routes of
administration
Oral[1]
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Onset of actionSlow over 3 hours or rapid[1]
Duration of action18–24 hours[1]
Identifiers
  • 1-(2,5-dimethoxy-3,4-dimethylphenyl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H21NO2
Molar mass223.316 g·mol−1
3D model (JSmol)
  • COc1c(C)c(C)c(cc1CC(C)N)OC
  • InChI=1S/C13H21NO2/c1-8(14)6-11-7-12(15-4)9(2)10(3)13(11)16-5/h7-8H,6,14H2,1-5H3 checkY
  • Key:RBZXVDSILZXPDM-UHFFFAOYSA-N checkY
  (verify)

Ganesha (G or G-0), also known as 3,4-dimethyl-2,5-dimethoxyamphetamine or as 3-methyl-DOM, is a psychedelic drug of the phenethylamine, amphetamine, and DOx families.[1] It is the 3-methyl derivative of DOM and the amphetamine (α-methyl) derivative of 2C-G.[1] The drug is taken orally.[1]

Use and effects

[edit]

In his book PiHKAL (Phenethylamines I Have Known and Loved), Alexander Shulgin lists Ganesha's dose range as 24 to 32 mg orally and its duration as 18 to 24 hours.[1] The drug's onset was variably described as slow over the course of 3 hours or as rapid.[1] The effects of Ganesha have been reported to include strong closed-eye visuals, an increased appreciation of music, and powerful relaxation and tranquility, among others.[1] Shulgin named Ganesha after the Hindu deity, Ganesha.[1] It is one of his "ten classic ladies", a series of methylated DOM derivatives.[1][2]

Interactions

[edit]

Chemistry

[edit]

Synthesis

[edit]

The chemical synthesis of Ganesha has been described.[1]

Homologues

[edit]

Homologues of Ganesha (G-0) include G-3, G-4, G-5, and G-N, among others.[1]

CompoundDetailsStructure
G-3 CAS #: 207740-36-1

Dose: 12–18 mg
Duration: 8–12 hours
Effects: Closed-eye imagery, no visuals, fantasy, no body load, neurological sensitivity, others
2C analogue: 2C-G-3

G-4 CAS #: Unknown

Partially synthesized but not tested.
2C analogue: 2C-G-4

G-5 CAS #: 133787-68-5

Dose: 14–20 mg
Duration: 16–30 hours
Effects: No visuals or other sensory effects, excellent mental activity, mental integration, lacking something important, little or no body load
2C analogue: 2C-G-5

G-N CAS #: 477904-62-4

Synthesized and tested at 2 mg but not up to active levels
2C analogue: 2C-G-N

G-O[3] CAS #: 774538-38-4

Described and/or synthesized but not tested
2C analogue: None

History

[edit]

Ganesha was first described in the literature by Alexander Shulgin in his book PiHKAL (Phenethylamines I Have Known and Loved) in 1991.[1]

Society and culture

[edit]
[edit]

Ganesha is a controlled substance in Canada under phenethylamine blanket-ban language.[4]

United Kingdom

[edit]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[5]

United States

[edit]

Ganesha is not an explicitly controlled substance in the United States.[6] However, it could be considered a controlled substance under the Federal Analogue Act if intended for human consumption. In addition, the drug may considered a controlled substance as a positional isomer of DOET.[6][7]

See also

[edit]

References

[edit]
  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628. http://www.erowid.org/library/books_online/pihkal/pihkal085.shtml
  2. Ger A, Ger D (April 2011). "Triple Goddess of the Night". British Neuroscience Association Bulletin. 63: 28–30.
  3. Hellberg MR, Namil A. Benzopyran analogs and their use for the treatment of glaucoma. Patent US 7396856
  4. "Controlled Drugs and Substances Act". Department of Justice Canada. Retrieved 19 January 2026.
  5. "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Archived from the original on 22 October 2017. Retrieved 12 March 2014.
  6. 1 2 Orange Book: List of Controlled Substances and Regulated Chemicals (January 2026) (PDF), United States: U.S. Department of Justice: Drug Enforcement Administration (DEA): Diversion Control Division, January 2026
[edit]